NY bio co. gets $4.6M from Russia to develop drugs

6 ways to lower blood pressure

One in three Americans will have high blood pressure at least …

Skin: Battling the 'Over the Hill' myth

Do you remember that whole line of “Over the Hill” birthday …

'Pay to delay' deals can be illegal

Reverse payment settlements arise when generic companies file a…

Grow lab organs to ease shortage?

Two years ago, Angela Irizarry of Lewisburg, Pa., needed a …

Pool precautions

Pediatrician Dr. Jim Fortenberry offers safety tips for the …

Initiative focuses on anti-infection drugs

Updated: Wednesday, 28 Nov 2012, 4:35 PM EST
Published : Wednesday, 28 Nov 2012, 4:35 PM EST

The Associated Press

BUFFALO, N.Y. (AP) - A western New York company says it has signed a $4.6 million contract with Russia to develop anti-infection drugs.

Buffalo-based Cleveland BioLabs Inc. says the contract with the Ministry of Industry and Trade of the Russian Federation was issued under the federation's "Pharma 2020" pharmaceutical development initiative.

The contract announced Tuesday focuses on Xenomycins, a family of compounds being developed as potential treatments for infectious diseases. It's being handled through Panacela Labs, a biotechnology startup company that was founded last year as a joint venture between Cleveland BioLabs and a Russian investment company.

NY bio co. gets $4.6M from Russia to develop drugs

Initiative focuses on anti-infection drugs

Site Tools